Matresa secures £315k for preventative pregnancy screening
Published
Matresa Limited provides clinical-grade maternal health infrastructure for early screening and risk identification, recently securing an estimated £315k in new funding. Based in Leamington Spa, the company offers continuous care during pregnancy, the postpartum period, and the transition back to work.
By combining clinical expertise with behavioral science and AI, the platform supports mothers through the transition to parenthood without replacing existing clinical care. The business partners with healthcare providers, insurers, and employers to offer preventative support aimed at improving long-term workforce retention and population health outcomes.
Incorporated in April 2025, the startup currently lists seven employees on its team. The recent funding follows a share allotment that took place in February 2026, with the corresponding documentation filed in September 2026.
Beverley Alison Brown was appointed as a director in January 2026. LinkedIn profiles suggest Brown is an angel investor and strategist who holds several non-executive director and board advisory positions.
Contact the editorial team at editorial@fundingspotter.com